MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Motor and non-motor symptoms in Parkinson’s disease: Correlation and impact on quality of life and activities of daily living

    P. Bugalho, T. Lampreia, R. Miguel, M. Mendonça, A. Caetano, R. Barbosa (Lisbon, Portugal)

    Objective: To evaluate the prevalence, interrelation and impact on health related quality of life (HRQL) and Activities of daily Living (ADL) of motor (MS) and…
  • 2016 International Congress

    Pulmonary dysfunction in Parkinson’s disease: A feature of early disease?

    G. Baille, T. Perez, D. Devos, L. Defebvre, C. Moreau (Lille, France)

    Objective: To characterize the abnormalities in pulmonary function tests (PFT) in early-diagnosed PD patients and to assess their prognostic features 2 years after. Background: Pulmonary…
  • 2016 International Congress

    Clinical correlates of depression and anxiety in patients with Parkinson’s disease

    H.D. Hambardzumyan, H.M. Manvelyan (Yerevan, Armenia)

    Objective: To clarify whether depression and anxiety are similar in terms of their associations with other clinical variables. Background: Although depression and anxiety are important…
  • 2016 International Congress

    Retinal nerve fiber layer thinning: A window into rapid eye movement sleep behavior disorders in Parkinson’s disease

    C.J. Mao, Z.J. Yang, J. Wei, J.R. Zhang, Y.P. Yang, C.F. Liu (Suzhou, People's Republic of China)

    Objective: To determine whether retinal structures are altered with the onset of rapid eye movement (REM) in Parkinson's disease (PD). Background: Rapid eye movement (REM)…
  • 2016 International Congress

    Parkinson’s disease prodromal dysautonomia versus pure autonomic failure and MSA

    M. Rosso, A. Merola, A.J. Espay, S. Maule, M. Zibetti, A. Romagnolo, L. Lopiano (Torino, Italy)

    Objective: To report the long-term follow-up (10 years) of a patient with severe autonomic dysfunction as presenting symptom of Parkinson's disease (PD), analyzing the possible…
  • 2016 International Congress

    Dophaminergic therapy and its influence on the olfactory function of patients with Parkinson’s disease

    O. Izhboldina, I. Zhukova, N. Zhukova, V. Alifirova, A. Latypova, M. Nikitina, Y. Mironova (Tomsk, Russia)

    Objective: The aim of this study was to investigate effects of dophaminergic therapy on olfaction of patients with Parkinson's disease. Background: Influence of dopaminergic drugs…
  • 2016 International Congress

    Clinical features of Parkinson’s disease patients developing stridor with acute respiratory failure

    J. Tashiro, S. Hamada, H. Soma, M. Nonaka, S. Honma, K. Hamada, A. Takei, F. Moriwaka, K. Tashiro (Sapporo, Japan)

    Objective: To clarify the clinical features of Parkinson's disease patients who developed stridor with acute respiratory failure due to vocal cord paralysis or laryngeal dystonia.…
  • 2016 International Congress

    An innovative international educational network to improve physicians’ current management practices of patients with cervical dystonia and spasticity

    C. Colosimo, K. Bhatia, R. Bhidayasiri, T.M. Chung, L.J. Jacinto, T. Landreau, K. Fheodoroff (Terni, Italy)

    Objective: The Ixcellence Network® aims to improve patient care in the fields of cervical dystonia (CD) and spasticity through the development of a high level…
  • 2016 International Congress

    Statistical aspects when exploring the association between change in body mass index (BMI), UPDRS scores and survival in the NET PD long-term study-1

    A. Perez, A.M. Wills, J. Wang, X. Su, J. Morgan, S.S. Rajan, M. Leehey, G.M. Pontone, K.L. Chou, C. Umeh, Z. Mari, J. Boyd, For the NINDS NET-PD Investigators (Austin, TX, USA)

    Objective: To report the statistical analyses exploring the association between BMI and change in Unified Parkinson's disease Rating Scale (UPDRS) scores and survival in the…
  • 2016 International Congress

    Cardiometabolic syndrome and risk of Parkinson’s disease: A case-control study in Mexican population

    G. Parra-López, L. Bazán-Rodríguez, M. Rodríguez-Violante, A. Cervantes-Arriaga, A. Jorge de Saráchaga, M. Escobar-Barrios, E. Carreón-Bautista (Mexico City, Mexico)

    Objective: To determine the role of cardiometabolic syndrome such as type 2 diabetes mellitus, hypertension, obesity, dyslipidemia and the risk of developing Parkinson's disease. Background:…
  • « Previous Page
  • 1
  • …
  • 182
  • 183
  • 184
  • 185
  • 186
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley